Quadruple Marker with Graph - 2nd Trimester in New Delhi
Understanding Quadruple Marker with Graph - 2nd Trimester in New Delhi
What is Quadruple Marker with Graph - 2nd Trimester in New Delhi?
A Quadruple Marker with Graph - 2nd Trimester is the most common blood screening test done between the 15th and 22nd week (second trimester) of pregnancy to determine whether the baby is at risk for certain birth defects. It offers valuable information to ensure the well-being of both the mother and the unborn child.
What does Quadruple Marker with Graph - 2nd Trimester measure?
Contains 3 testsThe Quadruple Marker with Graph - 2nd Trimester test measures the levels of four specific markers in the blood of a pregnant woman. These markers are -Alpha-Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), Unconjugated Estriol, and Inhibin-A.
The analysis of these four markers along with other factors like maternal age, and gestational age, helps assess the risk of certain conditions in the developing baby. The graph in Quadruple Marker with Graph - 2nd Trimester provides a visual representation of the levels of these markers during pregnancy.
It is noteworthy that Quadruple Marker with Graph - 2nd Trimester is a screening test and any abnormal results may prompt further diagnostic testing for confirmation. Pregnant women should discuss their results and implications with their doctor.
Inhibin A
Inhibin A is a hormone produced by the placenta. Abnormal levels may suggest an increased risk of chromosomal abnormalities.
Know more about Inhibin A
HCG Beta Total Quantitative, Maternal
An HCG Beta Total Quantitative, Maternal test measures the levels of human chorionic gonadotropin (hCG) hormone in the blood. hCG is released in the blood during pregnancy and can be detected as early as 10 days after conception. The levels of this hormone gradually rise every 2 to 3 days (or 48 to 72 hours) and peak around 8 to 11 weeks after conception. After reaching the peak, the hCG levels decrease and remain steady for the rest of the pregnancy.
Know more about HCG Beta Total Quantitative, Maternal
Unconjugated Estriol
Unconjugated Estriol is a type of estrogen hormone produced by the placenta. Abnormal levels may suggest an increased risk of the developing baby being born with chromosomal abnormalities.
Know more about Unconjugated Estriol
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Quadruple Marker with Graph - 2nd Trimester in New Delhi
Frequently Asked Questions about Quadruple Marker with Graph - 2nd Trimester in New Delhi
Q. What is a Quadruple Marker with Graph - 2nd Trimester test, and why is it important?
Q. What tests are done in a quad marker test?
Q. When can I go for a quad marker test during my pregnancy?
Q. How is a quad marker test performed, and is it safe for the baby?
Q. What chromosomal abnormalities are screened by a quad marker test?
Q. Does Tata 1mg Labs offer a quad marker test in New Delhi?
Q. Is home sample collection facility available for a quad marker test in New Delhi with Tata 1mg Labs?
Q. How can I schedule a quad marker test with Tata 1mg Labs in New Delhi?
Q. What is the price of a quad marker test at Tata 1mg Labs in New Delhi?
Q. How can I get my quad marker test report from Tata 1mg?
Q. What is the estimated turnaround time for the results of a quad marker test in New Delhi?
Book Quadruple Marker with Graph - 2nd Trimester at-home
References
- Greene ND, Copp AJ. Neural tube defects. Annu Rev Neurosci. 2014;37:221-42. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486472/#:~:text=Neural%20tube%20defects%20(NTDs)%2C,both%20genetic%20and%20environmental%20factors.
- Screening for Down's syndrome, Edwards' syndrome and Patau's syndrome [Internet]. NHS; 19 April 2021 [Accessed 20 Dec. 2023]. Available from: https://www.nhs.uk/pregnancy/your-pregnancy-care/screening-for-downs-edwards-pataus-syndrome/#:~:text=Combined%20test-,A%20screening%20test%20for%20Down's%20syndrome%2C%20Edwards'%20syndrome%20and%20Patau's,as%20the%2012%2Dweek%20scan.
- Sablok A, Sharma A, Ahmed CS, Kaul A. Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience. Indian J Med Res. 2021 May;154(5):716-722. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210531/
- Gordon S, Umandap C, Langaker MD. Prenatal Genetic Screening. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557702/
- Güdücü N, Görmüş U, Güner Eİ, Güzel O, Kavak ZN. Quadruple test parameters in art pregnancies. Int J Clin Exp Med. 2014 Aug 15;7(8):2319-23. PMID: 25232428; PMCID: PMC4161588. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161588/
- Commit to Healthy Choices to Help Prevent Birth Defects [Internet]. CDC; 28 June 2023 [Accessed 20 Dec. 2023]. Available from: https://www.cdc.gov/ncbddd/birthdefects/prevention.html
- Institute of Medicine (US) Committee on Improving Birth Outcomes; Bale JR, Stoll BJ, Lucas AO, editors. Reducing Birth Defects: Meeting the Challenge in the Developing World. Washington (DC): National Academies Press (US); 2003. 3, Interventions to Reduce the Impact of Birth Defects. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK222083/
- Boonpiam R, Wanapirak C, Sirichotiyakul S, Sekararithi R, Traisrisilp K, Tongsong T. Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study. BMC Pregnancy Childbirth. 2020 Oct 15;20(1):621. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559175/
Other tests
